 |
|
Does reduction of the oncologic safety margin for facial basal cell carcinoma result in higher recurrence rates?
Eon Su Kim, Chae Eun Yang, Yoon Kyu Chung
Arch Craniofac Surg. 2021;22(3):135-140. Published online 2021 Jun 25 DOI: https://doi.org/10.7181/acfs.2021.00206
|
|
Citations to this article as recorded by
 Benign and malignant cutaneous nasal lesions
Hamed Sarikhani, Karena Zhao, Marc A. Polacco, Charles Gropper, Samuel N. Helman
Eye & ENT Research.2024;[Epub] CrossRef Facial basal cell carcinoma: A retrospective study of 67 cases
Afrah A Khalil, Hamid H Enezei, Tahrir N Aldelaimi, Raid M Al-Ani
World Journal of Clinical Cases.2023; 11(7): 1488. CrossRef Adequacy of surgical margins, re-excision, and evaluation of factors associated with recurrence: a retrospective study of 769 basal cell carcinomas
Yıldız Gürsel Ürün, Nuray Can, Merve Bağış, Sezgi Sarıkaya Solak, Mustafa Ürün
Anais Brasileiros de Dermatologia.2023; 98(4): 449. CrossRef European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023
Ketty Peris, Maria Concetta Fargnoli, Roland Kaufmann, Petr Arenberger, Lars Bastholt, Nicole Basset Seguin, Veronique Bataille, Lieve Brochez, Veronique del Marmol, Reinhard Dummer, Ana-Marie Forsea, Caroline Gaudy-Marqueste, Catherine A. Harwood, Axel H
European Journal of Cancer.2023; 192: 113254. CrossRef Surgical refinement of the purse-string suture for skin and soft tissue defects of the head and neck
Hyochun Park, Yunjae Lee, Hyeonjung Yeo, Hannara Park
Archives of Craniofacial Surgery.2021; 22(4): 183. CrossRef
|